1 / 1

Supplemental Figure 1

Supplemental Figure 1. B. A. g H2AX. TRF1. Merge. 100. Untreated. 80. 60. % of TIFs positive cells. 40. RHPS4. 20. 0. _. RHPS4. siTRF2. siPOT1. CPT. IR. siTRF2. siPOT1. CPT. IR.

azana
Download Presentation

Supplemental Figure 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1 B A gH2AX TRF1 Merge 100 Untreated 80 60 % of TIFs positive cells 40 RHPS4 20 0 _ RHPS4 siTRF2 siPOT1 CPT IR siTRF2 siPOT1 CPT IR Figure Legend: BJ-EHLT fibroblasts were exposed to the following treatments: 0.5 M RHPS4 for 24 hrs, 2 M camptothecin for 2 hrs (CPT) and 5 Gy ionizing radiation (IR). Cells were also transfected with 100 nM of siTRF2 and siPOT1 for 48 hrs. siGFP was used as negative control of transfection. Co-immunofluorescence against -H2AX (green) and TRF1 (red) to mark telomeres in the indicated samples. (A) Representative images of IF acquired with a Leica Deconvolution microscope (magnification 100x). (B) Percentage of TIFs-positive cells, defined as cells with more than four -H2AX/TRF1 colocalization. The mean of three independent experiments with comparable results is shown. Error bars indicate  SD.

More Related